BioNTech SE Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities
BioNTech SE (BNTX) reported Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities of EUR 88.20 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities · last filed 2026-03-10
| Period end | Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities 12 month | Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities 12 month as first filed |
|---|---|---|
| 2025-12-31 | 88.20M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 0.00 EUR 20-F · filed 2023-03-27 | |
| 2021-12-31 | 1.30M EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 35.00M EUR 20-F/A · filed 2022-10-26 | 35.05M EUR 20-F · filed 2021-03-30 |